AMENDMENT NO. 3 TO AGENCY AGREEMENT
QuickLinks -- Click here to rapidly navigate through this document
AMENDMENT NO. 3
TO
AGENCY AGREEMENT
This Agreement No. 3 to Agency Agreement (this "Agreement") is entered into as of the 30th day of November 2000 with reference to that certain Agency Agreement between XXXXX Insurance Company and Pan American Underwriters, Inc. dated as of March 1, 1992, as amended (the "Agreement"). All capitalized terms used herein without definition shall have the meaning ascribed to them in the Agreement.
In consideration of the mutual covenants set forth herein and other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, the Agent and the Company agree to amend the Agreement as follows:
- 1.
- The relevant provisions of Schedule C to the Agreement are hereby amended as follows:
"The Company agrees to pay to the Agent the following bonus commission during the 2000 calendar year contingent upon the Agent meeting the following quarterly premium volume thresholds:
| Invoiced Quarterly 2000 Premium Volume |
Bonus Commission |
|
|---|---|---|
| $750,000 | 1% of Invoiced Premium | |
| $1,500,000 | Additional 1% of Invoiced Premium | |
| $2,250,000 | Additional 1% of Invoiced Premium | |
| $3,500,000 | Additional 1% of Invoiced Premium |
The foregoing will be paid quarterly based on invoiced premium written prior to the end of the applicable quarter. The bonus will apply to all premium written, not merely the amount of premium over the premium threshold. The bonus will be subject to offset to the same extent as commissions payable under this Agreement."
2. In all other respects, the Agreement (including the unamended provisions of Schedule C) shall continue in full force and effect.
IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the date first written above:
XXXXX INSURANCE COMPANY |
PAN AMERICAN UNDERWRITERS, INC. |
||||
By: |
/s/ XXXXXXX X. XXXXXX |
By: |
/s/ XXXXX X. XXXXXXXXX |
||
EXHIBIT 10.39
AMENDMENT NO. 3 TO AGENCY AGREEMENT
